FDIC Proposed Stablecoin Framework; 13% of Firms Report Actual Usage
The FDIC this week released its proposed rule under the GENIUS Act, tying stablecoin issuance to reserve integrity, liquidity discipline and custodial…
The FDIC this week released its proposed rule under the GENIUS Act, tying stablecoin issuance to reserve integrity, liquidity discipline and custodial…
GSK is planning five Phase 3 studies for an antibody-drug conjugate it licensed from Chinese partner Hansoh Pharma, targeting gynecological cancers.
A federal judge suspended most of the Trump administration's appointments to the CDC's Advisory Committee on Immunization Practices, but a newly published…
Julius Baer has been counting losses for two years.
Blackstone filed confidential IPO paperwork with U.S. regulators to raise $2 billion for a dedicated acquisition vehicle targeting data centers, Bloomberg…
The CFTC named five senior advisors to its Innovation Task Force on April 10, setting up a formal rule-writing process for crypto assets, artificial…
Denis Beau, first deputy governor of the Bank of France, told EU policymakers at the Eurofi High Level Seminar on March 26 that the Markets in Crypto-Assets…
A Phoenix federal judge on Friday temporarily blocked Arizona from enforcing its gambling laws against federally regulated prediction markets.
A Connecticut federal judge ruled Mallinckrodt's Irish unit can't escape a state price-fixing suit after a five-year jurisdictional delay.
Novo Nordisk is losing a key obesity figure.
Shionogi has been awarded a $119 million contract from BARDA for Fetroja, a direct government commitment to the drugmaker's drug.
The FDIC proposed a 191-page Genius Act stablecoin rule Tuesday, its second under the Act.
Jeito Capital closed Jeito II at more than €1bn, lifting the firm's total AUM to €1.6bn.
BARDA paid $482m to get Fetroja made on US soil.
Roche is paying $20 million upfront for access to two degrader-antibody conjugate (DAC) programs from C4 Therapeutics, with more than $1 billion in…